Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

  1. Harter, P.
  2. Mouret-Reynier, M.A.
  3. Pignata, S.
  4. Cropet, C.
  5. González-Martín, A.
  6. Bogner, G.
  7. Fujiwara, K.
  8. Vergote, I.
  9. Colombo, N.
  10. Nøttrup, T.J.
  11. Floquet, A.
  12. El-Balat, A.
  13. Scambia, G.
  14. Guerra Alia, E.M.
  15. Fabbro, M.
  16. Schmalfeldt, B.
  17. Hardy-Bessard, A.-C.
  18. Runnebaum, I.
  19. Pujade-Lauraine, E.
  20. Ray-Coquard, I.
Aldizkaria:
Gynecologic Oncology

ISSN: 1095-6859,  0090-8258

Argitalpen urtea: 2022

Alea: 164

Zenbakia: 2

Orrialdeak: 254-264

Mota: Artikulua

DOI: 10.1016/J.YGYNO.2021.12.016 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus